首页> 外文期刊>Modern Pathology >Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning
【24h】

Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning

机译:使用角蛋白免疫组化评估个体肿瘤芽:中度interobserver协议表明机器学习的作用

获取原文
       

摘要

Tumor budding is a promising and cost-effective biomarker with strong prognostic value in colorectal cancer. However, challenges related to interobserver variability persist. Such variability may be reduced by immunohistochemistry and computer-aided tumor bud selection. Development of computer algorithms for this purpose requires unequivocal examples of individual tumor buds. As such, we undertook a large-scale, international, and digital observer study on individual tumor bud assessment. From a pool of 46 colorectal cancer cases with tumor budding, 3000 tumor bud candidates were selected, largely based on digital image analysis algorithms. For each candidate bud, an image patch (size 256 256 m) was extracted from a pan cytokeratin-stained whole-slide image. Members of an International Tumor Budding Consortium (n = 7) were asked to categorize each candidate as either (1) tumor bud, (2) poorly differentiated cluster, or (3) neither, based on current definitions. Agreement was assessed with Cohen's and Fleiss Kappa statistics. Fleiss Kappa showed moderate overall agreement between observers (0.42 and 0.51), while Cohen's Kappas ranged from 0.25 to 0.63. Complete agreement by all seven observers was present for only 34% of the 3000 tumor bud candidates, while 59% of the candidates were agreed on by at least five of the seven observers. Despite reports of moderate-to-substantial agreement with respect to tumor budding grade, agreement with respect to individual pan cytokeratin-stained tumor buds is moderate at most. A machine learning approach may prove especially useful for a more robust assessment of individual tumor buds.
机译:肿瘤芽是一种有前途和成本效益的生物标志物,具有较强的结肠直肠癌预后价值。然而,与Interobserver可变性相关的挑战持续存在。免疫组织化学和计算机辅助肿瘤芽选择可以减少这种可变性。为此目的的计算机算法的开发需要个体肿瘤芽的明确例。因此,我们对个体肿瘤芽评估进行了大规模,国际和数字观察者研究。从46种结肠直肠癌病例中,选择了3000个肿瘤芽候蛋白,主要基于数字图像分析算法。对于每个候选芽,从PAN细胞角蛋白染色的整个滑动图像中提取图像贴片(大小256256m)。被要求将每种候选人(n = 7)分类为(1)肿瘤芽,(2)差异不良的聚类,或(3),基于当前定义,将各候选人分类为(1)患者。协议是用Cohen和Fleiss Kappa统计评估的。 Fleiss Kappa在观察者之间显示了适度的整体协议(0.42和0.51),而科恩的Kappas从0.25到0.63之间。所有七位观察员的完全协议只有3000名肿瘤芽候者的34%,而59%的候选人将七个观察员中的至少五次达成一致。尽管关于肿瘤崭露头角等级的中等至大幅度协议的报告,但对个体泛细胞角蛋白染色肿瘤芽的协议至多。机器学习方法可能对个体肿瘤芽的更强大的评估尤其有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号